Current Status of and Progress in Research on Obstructive Sleep Apnea and Comorbid Depressive Disorders
Abstract
Obstructive sleep apnea (OSA) and depressive disorders are common diseases in adults and they share in common many clinical symptoms, including sleep disturbance, fatigue, lack of concentration and cognitive function impairment. OSA and depressive disorders also share some common pathophysiological changes, including increased activity of the hypothalamic-pituitary-adrenal (HPA) axis, chronic low-grade inflammation, oxidative stress, and changes in gut microbiota and neurotransmitters, which may contribute to the comorbidity of OSA and depressive disorders. In the case of comorbid OSA and depressive disorders, OSA and depressive disorders may affect and exacerbate each other, thereby increasing the severity of diseases, entailing greater risk of cardiovascular and metabolic diseases, and causing greater difficulty in treatment. Herein, we summarized the latest research findings on the epidemiology, possible mechanisms, harms, and treatment of comorbid OSA and depressive disorders. This review may help improve clinicians' understanding of the comorbidity of OSA and depression disorders, thereby promoting early screening, prompt diagnosis and treatment, and improved prognosis. Further studies are needed for better understanding of the effect of the comorbidity of OSA and depressive disorders and treatment on cardiometabolic diseases.
Keywords: Obstructive sleep apnea, Depressive disorder, Comorbidity, Mechanism, Continuous positive airway pressure
Full Text:
PDFReferences
HEINZER R, VAT S, MARQUES-VIDAL P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med,2015,3(4): 310–318. doi: 10.1016/S2213-2600(15) 00043-0.
JORDAN A S, MCSHARRY D G, MALHOTRA A. Adult obstructive sleep apnoea. Lancet,2014,383(9918): 736–747. doi: 10.1016/S0140-6736 (13)60734-5.
MALHI G S, MANN J J. Depression. Lancet,2018,392(10161): 2299–2312. doi: 10.1016/S0140-6736(18)31948-2.
SILVEIRA M G, SAMPOL G, MOTA-FOIX M, et al. Cluster-derived obstructive sleep apnea phenotypes and outcomes at 5-year follow-up. J Clin Sleep Med,2022,18(2): 597–607. doi: 10.5664/jcsm.9674.
ACKER J, RICHTER K, PIEHL A, et al. Obstructive sleep apnea (OSA) and clinical depression-prevalence in a sleep center. Sleep breath,2017, 21(2): 311–318. doi: 10.1007/s11325-016-1411-3.
GARBARINO S, BARDWELL W A, GUGLIELMI O, et al. Association of anxiety and depression in obstructive sleep apnea patients: a systematic review and meta-analysis. Behav Sleep Med,2020,18(1): 35–57. doi: 10. 1080/15402002.2018.1545649.
PEPPARD P E, SZKLO-COXE M, HLA K M, et al. Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med,2006,166(16): 1709–1715. doi: 10.1001/archinte.166.16.1709.
KENDZERSKA T, GERSHON A S, HAWKER G A, et al. Obstructive sleep apnoea is not a risk factor for incident hospitalised depression: a historical cohort study. Eur Respir J,2017,49(6): 1601361. doi: 10.1183/ 13993003.01361-2016.
DAI Y, LI X, ZHANG X, et al. Prevalence and predisposing factors for depressive status in Chinese patients with obstructive sleep apnoea: a large-sample survey. PLoS One,2016,11(3): e0149939. doi: 10.1371/journal.pone.0149939.
SFORZA E, SAINT MARTIN M, BARTHÉLÉMY J C, et al. Mood disorders in healthy elderly with obstructive sleep apnea: a gender effect. Sleep Med,2016,19: 57–62. doi: 10.1016/j.sleep.2015.11.007.
EDWARDS C, MUKHERJEE S, SIMPSON L, et al. Depressive symptoms before and after treatment of obstructive sleep apnea in men and women. J Clin Sleep Med,2015,11(9): 1029–1038. doi: 10.5664/jcsm. 5020.
BJÖRNSDÓTTIR E, BENEDIKTSDÓTTIR B, PACK A I, et al. The prevalence of depression among untreated obstructive sleep apnea patients using a standardized psychiatric interview. J Clin Sleep Med, 2016,12(1): 105–112. doi: 10.5664/jcsm.5406.
STUBBS B, VANCAMPFORT D, VERONESE N, et al. The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: a systematic review and meta-analysis. J Affect Disord,2016,197: 259–267. doi: 10.1016/j.jad.2016.02. 060.
LOPRESTI A L, DRUMMOND P D. Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment. Prog Neuropsychopharmacol Biol Psychiatry,2013,45: 92–99. doi: 10.1016/j.pnpbp.2013.05.005.
GUPTA M A, SIMPSON F C. Obstructive sleep apnea and psychiatric disorders: a systematic review. J Clin Sleep Med,2015,11(2): 165–175. doi: 10.5664/jcsm.4466.
ROBILLARD R, SAAD M, RAY L B, et al. Selective serotonin reuptake inhibitor use is associated with worse sleep-related breathing disturbances in individuals with depressive disorders and sleep complaints: a retrospective study. J Clin Sleep Med,2021,17(3): 505–513. doi: 10.5664/jcsm.8942.
Refbacks
- There are currently no refbacks.